Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: "The story states that US sales for the product hit $99 million in 2008. But it never explained the cost to the individual. The study ""found no effect,"" the story states succinctly. The story said the researchers found the product to be safe. But it could have mentioned that the National Center for Complementary & Alternative Medicine states ""Side effects of ginkgo may include headache, nausea, gastrointestinal upset, diarrhea, dizziness, or allergic skin reactions. More severe allergic reactions have occasionally been reported."" Although the discussion was brief, it did refer to the study as ""properly designed"" and ""placebo controlled."" There was no disease-mongering of dementia or cognitive decline. 3 short quotes with different perspectives, presented in balance. In a story based on a study that pokes holes in some peoples’ beliefs about a product to prevent cognitive decline, there could have been at least one line about other research into cognitive decline. The widespread use of the product is clear in the story. The story states that the product has been in use for more than 500 years. We can’t be sure of the extent to which the story was influenced by a news release. it apparently did lift one quote from a news release/statement." Claim: Study: Ginkgo biloba has no effect on Alzheimer’s, dementia

A: In fewer words than its HealthDay competitor (404 words vs. 740), this story did a slightly better job on providing context and balance. Americans spend about $100 million a year on this stuff.
****
Q: Paragraph: "The story mentions that 30 capsules of OSR#1 cost $60. It would have been nice had the story also included information about the amount of active ingredient per capsule and the manufacturer’s recommended dosage. This would have allowed readers to make a better calculation as to the financial impact of treatment. This is critical information considering these costs will be borne out of pocket by anyone using OSR #1. The story juxtaposes a light-hearted ""success story"" with information about the industrial uses of OSR #1 for removing toxic heavy metals from contaminated soil. This is a clever way of way of emphasizing that the use of this product is based entirely on anecdote. The story clearly states that there is no credible evidence supporting the efficacy of the product. The harms of this product are impossible to quantify, given that it doesn’t seem to have been studied in humans or in animals. The story notes that other chelating drugs carry ""significant risks"" and ""can strip the body of metals necessary for health."" It would have been nice to see more specifics about what chelators can do, but the story satisfies the critierion. The story states that medical searches turned up no papers about OSR#1, and that the company which makes the product provided no published studies about its use. The story rightly suggests that this total lack of evidence should be deeply troubling. The story doesn’t exaggerate the prevalence or severity of autism, or of the potentially toxic compounds sometimes used to treat it. The story quotes multiple experts on pharmacology and an FDA spokesperson. It also quotes from an interview with Boyd Haley, president of the company which makes OSR #1. It attempted to get a reaction from Kim Stagliano, an OSR #1 proponent, but this effort was not successful. While the story mentions that there other are chelation drugs out there, it could have mentioned that there are educational strategies which can be helpful for children with autism and which have better evidence to support their use. The story states that OSR#1 is, according to the manufacturer’s website, available only through dentists’ or doctors’ offices. It notes, however, that the Tribune was able to buy 30 capsules of the product directly from a compounding pharmacy listed on the site. We are impressed that the Tribune went to these lengths to establish the product’s availability. The story provides a fairly detailed pedigree for OSR #1 and discusses its similarity to other chelation therapies used in the treatment of autism. It also gives credit to blogger Kathleen Seidel for being the first to raise concerns about OSR #1 in her blog, Neurodiversity.com The story is well sourced and is not based on a press release." Claim: Industrial chemical OSR#1 used as autism treatment

A: "The product known as OSR #1 contains a chemical originally intended for clean-up of toxic waste at industrial sites. This story by the Chicago Tribune (which was republished by the Los Angeles Times) examines how, despite a total lack of any research on the product in humans, OSR #1 ended up being marketed as a ""dietary supplement"" for children with autism. The story does an especially good job of pointing out the regulatory gaps which can allow risky, poorly researched products to be sold as ""cures"" to desperate parents and caregivers. It’s an example of health journalism doing what it’s supposed to do, and doing it well. Autism is a serious disorder which affects a growing number of children and their families and for which there are few good treatment options. This is a situation ripe for abuse by overzealous advocates and unscrupulous marketers of uNPRoven therapies. As Boyd Haley, president of the company that make the the OSR#1 supplement, puts it: ""There are so many snake oil salesmen out there, it’s just incredible."""
****
Q: Paragraph: With many unaware that half the population of 107 million had been told to stay home for a month, stranded workers crowded  checkpoints on the edges of Manila as vehicles tried to duck suspensions and police impounded taxis that were still running. “I need to make a living for my family,” said Albert Santos, 42, the driver of a passenger jeep, adding that he would try to make as much money before being forced to stop. “I can’t stop or they have nothing to eat.”  The Philippines is the first regional nation to take such drastic steps against the virus, which President Rodrigo Duterte described as “the fight of our lives”, after deeming existing curbs on movement and gatherings insufficient. In just 10 days, virus infections in the Philippines climbed to 142 from three, with 12 deaths. Malaysia will follow suit from Wednesday, closing borders, schools and most businesses, while restricting internal movement, after a daily jump of 125 cases to 553, nearly two-thirds of them linked to a major event at a mosque. Cambodia’s infections doubled to 24 on Tuesday and Thailand reported 30 new ones, taking its tally to 177, for a nearly threefold jump in a week. The regional trend casts more doubt on the view that warmer weather might stem the spread. Thailand’s cabinet agreed on Tuesday to close schools, cinemas, bars and entertainment centers, and postpone next month’s festivities for New Year in the mainly Buddhist nation. Manila’s usually busy business areas were almost deserted on the first morning of home quarantine, with only delivery trucks, police patrols and occasional private vehicles on the roads. City workers in protective suits disinfected public areas, security guards sat outside banks and convenience stores and workers trickled home after night shifts at call centers and medical clinics, among the few exemptions to Duterte’s curbs. Many shift workers were stranded after transport was suspended. Police pulled over dozens of taxis, with drivers - and many commuters - unaware of the new quarantine measures, announced on Monday afternoon and only clarified late at night. “I need to work. I don’t get paid if I don’t show up,” said Sheila Reyes, 24, as she waited hopefully for a ride to a factory, some of which are allowed to operate. “If I have to, I’ll walk to work.”  The measures widen a lockdown since Friday that brought immigration limits, curfews, closures of schools and malls, bans on gatherings, social distancing, and restrictions on movement for the capital. The Philippines suspended financial markets on Tuesday, the first trading shutdown in a world struggling to rein in the virus. Malaysia postponed a meeting this week of APEC finance officials. Philippine authorities said international airports in Manila and Clark would be closed to citizens, amid an expected exodus of foreigners before the expiry of a 72-hour deadline to leave. Teething troubles from the quarantine were inevitable and stranded people would receive help to get home and stay there, said Jonathan Malaya, an interior ministry official. “As expected, there still are people uninformed on last night’s announcement,” he said. “We have some kinks to fix ... it will normalize once people understand that they really need to stay home.”  In Bangkok’s Patpong area, famed for racy nightlife and counterfeit handbags, bar owners and workers said they were already suffering from the virus effect, and mandatory closures were probably for the best. “We have to follow the government’s measures,” said one bar worker, Kornpisit Kutakorn. “We have to do this for the common interest.” Claim: Confusion, concern as locked-down Philippines starts coronavirus quarantine.

A:
Millions of people woke up confused, confined and frustrated in the Philippines on Tuesday, as a sweeping home quarantine order kicked in with just a few hours of warning, and Southeast Asia prepared tighter measures against a surge in coronavirus cases.
****